Piper Jaffray Reiterates Overweight on NuVasive

Piper Jaffray is out with its report today on NuVasive NUVA, reiterating Overweight. In its report, Piper Jaffray writes, "After reviewing the key lingering issues putting pressure on NUVA we remain bullish on NUVA and recommend that investors buy the stock at current levels." Piper Jaffray maintains a $35 PT on NUVA. At the time of posting, shares of NUVA were trading at $19.35, up 3.53% from Thursday's close.